CSX vs RLMD · P/E 19, rev $14.09B vs $692.3M cap
CSX Corporation (CSX) versus Relmada Therapeutics Inc (RLMD) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
RLMD does not have a complete income-statement cache yet.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. RLMD currently screens at market cap $692.3M.
Not investment advice. Open the CSX and RLMD stock pages for the full models.
Not investment advice.